Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | 12,806,342 | reported | 18 Nov 2021 | tx 16+12,806,342−22,990,121 |
| Amylyx Pharmaceuticals, Inc. | 4,997,302 | reported | 15 Aug 2023 | tx 28+10,678,808−14,475,612 |
| Kezar Life Sciences, Inc. | 1,947,993 | reported | 15 Aug 2023 | tx 27+6,109,052−6,220,111 |
| Liquidia Technologies Inc | 442,819 | reported | 30 Jul 2018 | tx 6+571,724−5,589,670 |
| Environmental Impact Acquisition Corp | 0 | reported | 24 Jul 2023 | tx 6+16,919,412−30,777,343 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Aug 2023 | GIFT | Amylyx Pharmaceuticals, Inc. | 2,000,000 | 0.00 USD | |
| 15 Aug 2023 | GIFT | Kezar Life Sciences, Inc. | 3,500,000 | 0.00 USD | |
| 24 Jul 2023 | OTHER | Environmental Impact Acquisition Corp | 16,919,155 | — | |
| 29 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 29,048 | 30.45 USD | |
| 27 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 32,964 | 30.25 USD | |
| 27 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 28,000 | 30.80 USD | |
| 28 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 100,000 | 30.37 USD | |
| 21 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 28,807 | 32.17 USD | |
| 21 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 34,641 | 31.69 USD | |
| 16 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 9,122 | 32.55 USD | |
| 15 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 41,066 | 33.68 USD | |
| 15 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 108,934 | 33.12 USD | |
| 14 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 70,714 | 34.54 USD | |
| 02 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 50,000 | 33.75 USD | |
| 22 Feb 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 2,112 | 35.34 USD | |
| 22 Feb 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 47,888 | 34.70 USD | |
| 23 Feb 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 48,889 | 35.55 USD | |
| 22 Feb 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 10,084 | 36.34 USD | |
| 23 Feb 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 1,111 | 36.24 USD | |
| 22 Feb 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 39,916 | 35.91 USD | |
| 06 Feb 2023 | SALE | Kezar Life Sciences, Inc. | 40,000 | 6.88 USD | |
| 03 Feb 2023 | SALE | Kezar Life Sciences, Inc. | 25,000 | 7.15 USD | |
| 02 Feb 2023 | SALE | Kezar Life Sciences, Inc. | 50,000 | 7.19 USD | |
| 01 Feb 2023 | SALE | Kezar Life Sciences, Inc. | 40,000 | 6.95 USD | |
| 30 Jan 2023 | SALE | Kezar Life Sciences, Inc. | 30,000 | 6.91 USD |
1 purchase reported after at least 12 months of silence — most recent on 18 Nov 2021.